Meet the Researchers

Dr Neil McGregor (BDS, MDSc, PhD)


Honorary Senior Fellow, University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences

Adjunct Professor, Victoria University

Dr McGregor is a highly experienced ME/CFS researcher, having co-authored more than 40 papers in ME/CFS, over a period of more than 20 years. He has been the editor of the Journal of Chronic Fatigue Syndrome, and served on several editorial boards. Neil has been involved in research both in Australia and in the US ( Stanford University (California), University of Nevada (Nevada), Nova South-Eastern University (Florida)), and Europe. Neil’s research interests include chronic pain aetiology and treatment, chronic viral infections and viral reactivation processes and treatments, bacterial/host immune interactions and the resultant host pathology and the development of instruments to measure human pathology.

Chris Armstrong (BSc)

Researcher, Biochemistry & Molecular Biology

Bio21 Molecular Science & Biotechnology Institute (University of Melbourne)

Chris Armstrong has been researching ME/CFS for six years, and is a lead researcher for Melbourne Bioanalytics. Chris undertook his PhD in metabolomics in ME/CFS and, since then, his particular interest has been developing metabolomic methods for studying the impact of the gut microbiome on health, with a focus on ME/CFS. He is also interested in potential for personalised-omics to be utilised in the treatment and management of conditions like ME/CFS. Chris was lead author on the first ever metabolomics study undertaken in ME/CFS, which was published in 2012. In 2016, Chris presented the findings of the group’s gut microbe and metabolomics study at the internationally recognised Invest in ME (IiME) conference, in London.

Assoc Professor Paul Gooley (BSc, PhD)

Protein Biochemist

Bio21 Molecular Science & Biotechnology Institute (University of Melbourne)

Associate Professor Paul Gooley directs a structural biology research group at Bio21 Institute that focuses on the application of nuclear magnetic resonance (NMR) spectroscopy to highlight the structure and interactions of proteins. He obtained his degrees at the University of New South Wales, and spent 10 years in the USA, including five at the pharmaceutical company Merck and Co. Over the last 10 years, Paul’s group has conducted and published NMR structural and dynamical analyses on a number of protein domains and systems (5 to 35 kDa) that have biological functions in stress and infection (elicitin, diadenosine tetraphosphate hydrolase), in lipid transport (apolipoprotein CII), in protein and membrane trafficking (FYVE domain, Small Myristoylated Protein (flagellar biogenesis) and Tom20 of the mitochondrial import receptor), and receptor signalling (LDLa module of the relaxin receptor).


General Practitioner

Director, CFS Discovery

With a personal interest in the illness, Dr Lewis has dedicated his career to the research and treatment of ME/CFS, through the CFS Discovery clinic, which he founded in 1985. Dr Lewis was involved in the development of the International Consensus Criteria (ICC) for ME, which was published in 2011. He has been involved in teaching doctors about ME/CFS, and integrates latest research findings into his clinical approach with his patients. In addition to his clinical work, Dr Lewis has published research exploring abnormalities with sleep patterns, microbiota and orthostatic intolerance in ME/CFS, and is particularly interested in the role of gut dysbiosis in ME/CFS.

Henry Butt (MSc, PhD)


Director, Bioscreen

Honorary Senior Fellow, Bio21 Molecular Science & Biotechnology Institute (University of Melbourne)

Dr Butt has extensive experience in faecal microbiology. As Director of Bioscreen, a specialist facility in faecal microbial analysis, Henry has developed and refined testing procedures analysing the gut microbiome. Henry is particularly interested in gut dysbiosis and intestinal permeability, and their impact on nutrient absorption and cellular nutrition. Henry has worked as a Conjoint Lecturer, University of Newcastle, and was Scientist-in-Charge of the Department of Microbiology and Infectious Disease, for Hunter Area Health Services in NSW.

Dr John Whiting (FRACP)

Physician (Infectious Diseases, Internal Medicine)

Dr Whiting is a medical specialist in infectious diseases and internal medicine, who has concentrated his focus on ME/CFS and related conditions since 1987. Dr Whiting has an international reputation for his work, and presented at the International Association for ME/CFS (IACFS/ME) conference, in Florida, in 2016. Dr Whiting has a unique patient population of ME/CFS patients, as many have been under his care for 25 years. As such, he is privy to the consequences that these patients experience under various circumstances, including how they manage with and without appropriate care and specific medications over the long term.